Daniela Weiskopf Awarded $1.4 million to Study COVID-19 in Latino Americans
LA JOLLA, CA—Latino Americans have been hit very hard by the COVID-19 pandemic. In fact, the U.S. Centers for Disease
How Pandemics End
Nearly every pandemic has had an arc. A disease spreads, it kills, it stops. We don’t yet know how the
Every COVID-19 case seems different. These scientists want to know why.
LA JOLLA—As scientists around the world develop life-saving COVID-19 vaccines and therapies, many are still wondering exactly why the disease
New look at COVID-19 cases does not support link between BCG vaccination and lower mortality
Researchers tracking COVID-19 mortality early in the pandemic noticed that some countries had a significantly lower mortality rate than others.
T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity
LA JOLLA, CA—Ever since SARS-CoV-2 first appeared, researchers have been trying to understand whether sometimes the immune system does more
Beating HIV and COVID-19 may depend on tweaking vaccine molecules
LA JOLLA—Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune
LJI Professor Erica Ollmann Saphire awarded $6.4 million for international efforts to beat COVID-19
LA JOLLA—The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has awarded more
LJI team gets first-ever look at a rare but vital stem cell in humans
LA JOLLA—Neutrophils are the warriors of the immune system. They are always ready to spring to action to help heal
Forty percent of people with coronavirus infections have no symptoms. Might they be the key to ending the pandemic?
New research suggests that some of us may be partially protected due to past encounters with common cold coronaviruses
Why antibodies may not be the key to beating coronavirus
Worries over waning antibodies may be overblown, as growing evidence shows a role for T cells in the coronavirus immune response.
